ParaPRO

Since 2002, ParaPRO has advanced the clinical drug development and utility of Spinosad, a novel compound derived from a naturally occurring soil microorganism, to effectively address the unmet needs of medical conditions associated with human parasites such as scabies and head lice. Our purpose is clear: to bring the latest technology, science, and clinical expertise to bear to ensure the safety and health outcomes of the patients and practitioners we serve.